Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Taddei

Showing results (21-30 of 291) with videos related to

Pageof 30
Sort By:
European Heart Journal|June 5, 2012
Angiotensin-converting enzyme inhibitors: first-line agents in cardiovascular protection?Frank Ruschitzka, Stefano Taddei
European Cardiology|October 13, 2018
Resistant Hypertension: A Real Entity Requiring Special Treatment?Stefano Taddei, Rosa Maria Bruno
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Renal denervation: back to reality, finally!Stefano Taddei, Rosa Maria Bruno
Current Medical Research and Opinion|January 9, 2018
Vascular legacy beyond blood pressure control: benefits of perindopril/indapamide combination in hypertensive patients with diabetesBernard I Lévy, Stefano Taddei
European Heart Journal|September 7, 2018
Asleep blood pressure: a target for cardiovascular event reduction?Rosa Maria Bruno, Stefano Taddei
European Journal of Preventive Cardiology|April 18, 2023
Low-dose aspirin therapy for primary prevention of cardiovascular disease: where are we at?Nicola Riccardo Pugliese, Stefano Taddei
European Journal of Preventive Cardiology|August 16, 2018
Need for fixed combination therapy in type-2 diabetes: Findings from the SMART studyRosa M Bruno, Stefano Taddei
Journal of Hypertension|December 12, 2013
Renal denervation: still more questions than answersStefano Taddei, Rosa Maria Bruno
Journal of Hypertension|June 30, 2016
Endothelial dysfunction in hypertension: achievements and open questionsStefano Taddei, Rosa Maria Bruno
European Heart Journal|November 11, 2015
New-onset diabetes in hypertensive patients and mortality: timing is everythingRosa Maria Bruno, Stefano Taddei
Pageof 30

Showing results (21-30 of 291) with videos related to

Sort By:
Pageof 30
European Heart Journal|June 5, 2012
Angiotensin-converting enzyme inhibitors: first-line agents in cardiovascular protection?Frank Ruschitzka, Stefano Taddei
European Cardiology|October 13, 2018
Resistant Hypertension: A Real Entity Requiring Special Treatment?Stefano Taddei, Rosa Maria Bruno
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Renal denervation: back to reality, finally!Stefano Taddei, Rosa Maria Bruno
Current Medical Research and Opinion|January 9, 2018
Vascular legacy beyond blood pressure control: benefits of perindopril/indapamide combination in hypertensive patients with diabetesBernard I Lévy, Stefano Taddei
European Heart Journal|September 7, 2018
Asleep blood pressure: a target for cardiovascular event reduction?Rosa Maria Bruno, Stefano Taddei
European Journal of Preventive Cardiology|April 18, 2023
Low-dose aspirin therapy for primary prevention of cardiovascular disease: where are we at?Nicola Riccardo Pugliese, Stefano Taddei
European Journal of Preventive Cardiology|August 16, 2018
Need for fixed combination therapy in type-2 diabetes: Findings from the SMART studyRosa M Bruno, Stefano Taddei
Journal of Hypertension|December 12, 2013
Renal denervation: still more questions than answersStefano Taddei, Rosa Maria Bruno
Journal of Hypertension|June 30, 2016
Endothelial dysfunction in hypertension: achievements and open questionsStefano Taddei, Rosa Maria Bruno
European Heart Journal|November 11, 2015
New-onset diabetes in hypertensive patients and mortality: timing is everythingRosa Maria Bruno, Stefano Taddei
Pageof 30